Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

inhatarget.com

Founded Year

2018

Stage

Series A | Alive

Total Raised

$6.12M

Last Raised

$6.12M | 3 yrs ago

About InhaTarget Thereapeutics

InhaTarget Therapeutics develops targeted dry powders for inhalation that aim to improve the treatment of severe and/or chronic respiratory diseases.

InhaTarget Thereapeutics Headquarters Location

Université libre de Bruxelles (ULB), Unité de Pharmacie galénique et de biopharmacie. Campus de la Plaine CP 207, Boulevard du Triomphe

Bruxelles, 1050,

Belgium

+32 2 650 52 54

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing InhaTarget Thereapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

InhaTarget Thereapeutics is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

8,485 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,901 items

InhaTarget Thereapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

InhaTarget Thereapeutics Rank

  • When was InhaTarget Thereapeutics founded?

    InhaTarget Thereapeutics was founded in 2018.

  • Where is InhaTarget Thereapeutics's headquarters?

    InhaTarget Thereapeutics's headquarters is located at Université libre de Bruxelles (ULB), Unité de Pharmacie galénique et de biopharmacie., Bruxelles.

  • What is InhaTarget Thereapeutics's latest funding round?

    InhaTarget Thereapeutics's latest funding round is Series A.

  • How much did InhaTarget Thereapeutics raise?

    InhaTarget Thereapeutics raised a total of $6.12M.

  • Who are the investors of InhaTarget Thereapeutics?

    Investors of InhaTarget Thereapeutics include Sambrinvest, Theodorus, SMB Lab and Galephar Pharmaceutical Research.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.